October 5, 2020
Authored and Edited by Kyu Yun Kim; Maeve O'Flynn; Ningling Wang; Amanda K. Murphy, Ph.D.; K. Victoria Barker, Ph.D.; Thomas Lee Irving; Stacy Lewis*
Many patent owners are interested in trying to draft a single patent application that will serve them in several countries. This is ambitious, since there are many differences between various countries’ patent systems, but perhaps not impossible. The patent drafter just needs to be aware of and try to balance all the different requirements in the single patent application. This series of articles will outline some important considerations when drafting a single patent application. In our first article (available here), we reviewed the grace period provisions in the U.S., Korea, China, and the European Patent Office (“EPO”). In our second article (available here), we looked at how much data should be included on filing. Since the drafting requirements are different in each country, in this article, we will look at language we should be mindful of in drafting a patent application for multijurisdictional use. The article may be found on Finnegan’s AIA blog.
*Stacy Lewis is a Law Clerk at Finnegan
Copyright © 2020 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
At the PTAB Blog
Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a
§ 325(d) EPR Denial
May 28, 2026
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Webinar
Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement
May 18, 2026
Webinar
Federal Circuit IP Blog
When “and” and “e.g.” Matter: Federal Circuit Revives VLSI vs. Intel Case
May 14, 2026
INCONTESTABLE® Blog
Netflix Prevails in Copyright Infringement Suit Regarding Tiger King
May 14, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.